KRT19, CEACAM5 and EPCAM mRNA had been reported previously as promising tumor cell markers in LNs from NSCLC patients [17], whereas SFTPA and SFTPC were novel genes in this context. The gene discussed is EPCAM; the disease is non-small cell lung carcinoma.